Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06139354 · ClinicalTrials.gov registry record · NA

Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

A NA study of HIV, sponsored by University of Arkansas.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06139354 is a NA study of HIV that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 45 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06139354, a NA study of HIV, is actively recruiting participants, sponsored by University of Arkansas.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to pilot a digital, interactive patient-provider HIV PEP decision aid. The decision aid will incorporate five sections of content: 1) key clinical factors input by providers; 2) tailored multimedia-based HIV risk sharing information; 3) standardized multimedia educational messaging regarding the effectiveness, risks, and benefits of HIV PEP; 4) direct comparisons of priorities (e.g., physical well-being - "I want to do everything I can to prevent HIV," privacy - "I don't want others to know about the exposure," or cost - "I can't afford the pills'') completed by patients; and 5) tailored feedback regarding patient priorities for use in shared clinical decision making.

Conditions Studied

Interventions

  • BEHAVIORAL decision aid

Study Locations (1)

District of Columbia

  • District of Columbia Forensic Nurse Examiners - Washington D.C.

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-10-04
Est. Completion 2026-06
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT06139354

The ClinicalTrials.gov registry entry for NCT06139354 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (90% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which decision aid is the first listed.

NCT06139354 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06139354 about?

NCT06139354 is a clinical study titled "Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault". The goal of this trial is to pilot a digital, interactive patient-provider HIV PEP decision aid. The decision aid will incorporate five sections of content: 1) key clinical factors input by providers; 2) tailored multimedia-based HIV risk sharing information; 3) standardized multimedia educational m...

What is the current status of trial NCT06139354?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-10-04. Estimated completion is 2026-06.

What conditions does trial NCT06139354 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06139354?

The interventions under investigation include: decision aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT06139354?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06139354 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.